Unconventional Monetary Policy, and More from CRS
New and updated reports from the Congressional Research Service that Congress has chosen not to make available to the public include the following.
Federal Reserve: Unconventional Monetary Policy Options, February 19, 2013
Federal Assault Weapons Ban: Legal Issues, February 14, 2013
Pharmaceutical Patent Settlements: Issues in Innovation and Competitiveness, February 15, 2013
Unauthorized Aliens: Policy Options for Providing Targeted Immigration Relief, February 13, 2013
Cars, Trucks, and Climate: EPA Regulation of Greenhouse Gases from Mobile Sources, February 14, 2013
Japan-U.S. Relations: Issues for Congress, February 15, 2013
Exemptions for Firearms in Bankruptcy, February 15, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.